« asking for directions: the alli roadmap  | Main  | Unrealistic weight loss goals: who's responsible? »

Welcome to the official alli corporate blog

Welcome! alli is the only FDA-approved OTC (over the counter) weight loss product available for overweight adults. You've probably seen our advertising (see our TV ads). But what we're really interested in is what you, the users, are saying about alli, as well as what your questions are.

You are posting to message boards by the thousands, you are blogging about alli, you are creating videos about alli for YouTube. We've also gotten thousands of phone calls and letters since alli went on the shelf in mid-June 2007.

The goal of this blog is to have a two-way conversation with you -- not just about alli but about weight loss issues in general. We're going to challenge some common notions about weight loss. And we want you to challenge and question us in return.

We want to hear from you. Tell us your biggest issues about weight loss: is it keeping weight off over the long-term? Is it hitting a plateau? Is it learning to eat more healthfully? Is it the logistics of eating healthfully at every meal? Is it the value or efficacy of nutritional supplements? Is it how and when to exercise more?

We hope you'll talk back by leaving a Comment.

Learn more about the contributors to this blog here.

Other official alli resources

myalli.com (the product Web site)

alli message board 

Frequently Asked Questions

 

about this blog

  • alliConnect is GlaxoSmithKline's official corporate blog for alli, the only FDA-approved, OTC weight loss product. It's a place for you to have a conversation with us about weight loss issues. Because we work for a drug company we do have to abide by a few rules. Legal stuff...

Subscribe

  • RSS feed

    Enter your email address below to receive an email whenever a new entry is published.

comments policy

  • We want to hear from you! We review all comments in advance. Please stay on topic, be respectful of others' views and avoid profanity. More about our comments policy

Search this blog

Go

About the authors

contact us

about gsk